SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION...
(Updated to add more details and background; investor reaction; updates stock price.) By Peter Loftus Of DOW JONES NEWSWIRES Johnson & Johnson...
(Adds details and background throughout; comments from J&J CEO beginning in 5th paragraph; updates stock price.) By Peter Loftus Of DOW JONES...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Amendment No. 6...
- Johnson & Johnson Will Commence Subsequent Offering Period NEW BRUNSWICK, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE:JNJ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Amendment No. 5 ...
NEW BRUNSWICK, N.J., Jan. 15 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE:JNJ) today announced that all applicable foreign antitrust and...
NEW YORK, Jan. 14 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:...
By Jon Kamp Of DOW JONES NEWSWIRES Abbott Laboratories' (ABT) deal for Advanced Medical Optics Inc. (EYE), along with other smaller ones, shows...
SCHEDULE 13G Amendment No. 4 Mentor Corporation Common Stock Cusip #587188103 Cusip #587188103 Item 1: Reporting Person - FMR LLC Item 4:...
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response 10.4 UNITED STATES Securities and...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.